FOLH1 and prostate carcinoma: 2.3. Targeted Delivery of Doxorubicin to PMSA+ (PMSA, Prostate Specific Membrane Antigen) Prostate Cancer Cells Using A10-3-J1 Conjugated SPIO-NPs